Introduction
Escherichia coli and Klebsiella pneumoniae are the main gram-negative opportunistic pathogens in nosocomial infections [1, 2] . Virulent strains of E. coli mostly can cause urinary tract infections, neonatal meningitis, abdominal cramps, and diarrhea [3] [4] [5] . K. pneumoniae can cause clinical infections including respiratory tract infection, pneumonia, urinary tract infection, wound infection, and bacteremia [3] . Resistance to fluoroquinolones in clinical isolates of Enterobacteriaceae family was first studied in a K. pneumoniae strain [6, 7] . Recently, fluoroquinolone resistance has emerged in clinical strains of E. coli and K. pneumoniae [8, 9] . Mutations in topoisomerase IV and DNA gyrase and overexpression of AcrAB efflux system are the main mechanisms of quinolone resistance in E. coli and K. pneumoniae isolates [10] [11] [12] . Plasmid-mediated quinolone resistance (PMQR) mechanisms have also been reported: Qnr determinants, namely, QnrA, QnrB, QnrC, QnrD, and QnrS; QepA and OqxAB efflux pumps; and AAC(6′)-Ib-cr enzyme that acetylates aminoglycosides and ciprofloxacin [13] . Efflux pumps are transport proteins involved in the extrusion of toxic substrates from intracellular into the extracellular environment. AcrAB and QepA efflux pumps have been reported in clinical isolates of E. coli and K. pneumoniae. These efflux proteins can modify the permeability of the bacterial membrane by drug extrusion to outside, therefore the antibiotic resistance occurs. AcrAB and QepA multidrug-resistant efflux proteins belong to the major facilitator superfamily group and confers decreased susceptibility to quinolone. The aac(6′)-Ib-cr gene encodes the ability of quinolones acetylation such as ciprofloxacin and norfloxacin. Therefore, aac(6′)-Ib-cr gene can diminish susceptibility to quinolones in addition to aminoglycosides. The aim of this study was to report the prevalence of quinolone resistance genes, including qepA, aac(6′)-Ib-cr, acrA, and acrB genes, among E. coli and K. pneumoniae clinical strains isolated from three educational hospitals of Tehran, Iran.
Methods

Bacterial isolates
A total of 100 strains of E. coli from Labbafinejad and Taleghani Hospitals and 100 strains of K. pneumoniae from Mofid Children and Taleghani Hospitals were collected between January 2013 and May 2014. The following conventional biochemical tests were done: motility, indole, methyl red, Voges-Proskauer, ornithine decarboxylase and lysine decarboxylase, Simmons citrate test, and triple sugar iron.
Antimicrobial susceptibility testing
Antimicrobial susceptibility tests were performed by the Kirby-Bauer disk diffusion method (Mast Group Ltd., Merseyside, UK) according to Clinical and Laboratory Standards Institute guidelines [14] . The antimicrobial agents tested were cefpodoxime (30 μg), ciprofloxacin (30 μg), imipenem (10 μg), gentamicin (10 μg), amikacin (30 μg), ampicillin (10 μg), tigecycline (15 μg), cefotaxime (30 μg), ceftazidime (30 μg), levofloxacin (5 μg), and fosfomycin (50 μg). E. coli ATCC25922 was used as quality control strain.
PCR detection and DNA sequencing
The DNA was extracted by GeNet Bio company (Korea, Cat. no. K-3000) and used as a template for polymerase chain reaction (PCR). The quinolone resistance encoding genes, including qepA, aac(6′)-Ib-cr, acrA, and acrB genes were amplified for all E. coli and K. pneumoniae strains by means of PCR using the primer sets and thermal cycling conditions described in Tables I and II . PCR products were analyzed by electrophoresis in a 1%-1.5% agarose gel. One of the PCR products was purified and direct sequencing was done.
Statistical analysis
Our study was a descriptive study. Analysis of results was done by MINITAB16 software. P value and confidence intervals were <0.05 and 95%, respectively.
Results
In all the 100 strains of E. coli recovered, 70 strains were isolated from Labbafinejad Hospital (70%) and 30 from Taleghani Hospital (30%). A total of 33 strains were isolated from male patients (33%) and 67 from female patients (67%). In all the 100 strains of K. pneumoniae recovered, 50 strains were isolated from Mofid Children Hospital (50%) and 50 from Taleghani Hospital (50%). A total of 57 strains were isolated from male patients (57%) and 43 from female patients (43%). In this study, fosfomycin and imipenem against E. coli and fosfomycin and tigecycline against K. pneumoniae had the best effect in antimicrobial susceptibility tests. Antibiotic susceptibility testing results for clinical isolates of E. coli and K. pneumoniae are shown in Table III . The prevalence of qepA, aac(6′)-Ib-cr, acrA, and acrB genes among the 100 E. coli isolates was 0 (0%), 87 (87%), 92 (92%), and 84 (84%), respectively. The prevalence of qepA, aac(6′)-Ib-cr, acrA, and acrB genes among the 100 K. pneumoniae isolates was 4 (4%), 85 (85%), 94 (94%), and 87 (87%), respectively.
Discussion
First, PMQR genes were identified in Enterobacteriaceae family. Then, qnr determinants, including qnrA, qnrB, qnrC, qnrD, and qnrS, have been identified. Furthermore, AAC(6′)-Ib-cr that acetylates aminoglycosides and ciprofloxacin and qepA, which encodes an efflux pump, have been identified [15] . In this study, the prevalence of qepA gene among K. pneumoniae isolates was reported 4 (4%), but this gene was not seen among E. coli isolates. These results are consistent with the study performed by Chen et al. [16] in China, where 4.9% of qepA gene was positive. Despite this low prevalence rate, this plasmid-encoding gene, can be moved between hospitals and health-care centers increase the resistance rate. The AAC(6′)-Ib-cr causes decreased susceptibility to quinolones in addition to aminoglycosides. In this study, we showed that 87 (87%) clinical isolates of E. coli and 85 (85%) clinical isolates of K. pneumoniae carried aac(6′)-Ib-cr gene. This high prevalence rate of resistance is a serious threat to use both the quinolone and aminoglycoside drugs for treatment programs in the future. It was demonstrated in this survey that ciprofloxacin and levofloxacin had the most drug resistance against E. coli and K. pneumoniae isolates. The antibiotic susceptibility testing performed by Ma et al. [17] confirms our results. Recent studies reported several mechanisms for antimicrobial resistance ability among clinical isolates of E. coli and K. pneumoniae. AcrAB efflux pump is one of the main chromosomal mechanisms of resistance to quinolones in Enterobacteriaceae family [18] [19] [20] [21] . This efflux protein is one of the important mechanisms in multidrug-resistant E. coli and K. pneumoniae isolates. This study showed high prevalence rate of acrA and acrB genes among E. coli isolates, 92% and 84%, respectively, and in K. pneumoniae isolates, 94% and 87%, respectively. Since the neighboring countries of Iran have a similar distribution of quinolone resistance genes studied in this survey, the geographical location can play a key role in spreading of these genes. Recent studies showed increase in the quinolone-resistant clinical isolates of E. coli and K. pneumoniae among hospitalized patients in Iran [22, 23] . Much more investigations need to simplify the actual incidence rate of quinolones resistance encoding genes.
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